Veterinary Medicines

Nafpenzal DC 100 mg suspension intramammaire

Authorised
  • Nafcillin sodium
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine
Download as PDF

Product identification

Medicine name:
Nafpenzal DC 100 mg suspension intramammaire
Nafpenzal DC 100 mg Suspension zur intramammären Anwendung
Active substance:
  • Nafcillin sodium
  • Dihydrostreptomycin sulfate
  • Benzylpenicillin procaine
Target species:
  • Cattle (dairy cattle)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Nafcillin sodium
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Dihydrostreptomycin sulfate
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Benzylpenicillin procaine
    300.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (dairy cattle)
      • Meat and offal
        5
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • 20 Intramammary syringes with 3g of Intramammary suspension

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • V 817/02/11/0746
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 14/08/2023
Download